Want to get this daily news briefing by email? Here’s the sign-up.
WHAT WE’RE WATCHING
IMMUNE SUPPORT - The U.S. Food and Drug Administration’s full approval of the Pfizer-BioNTech coronavirus vaccine for people 16 and older could embolden more employers to require vaccination and certainly weakens employees’ attempts to litigate the issue. Still, getting the COVID-19 shot is like attending a Zoom happy hour, just because you can force your employees to do it, doesn’t necessarily mean you should. In this week’s Law.com Litigation Trendspotter column, we look at how Pfizer’s FDA approval has impacted the litigation landscape and why, despite the win for employers, attorneys still generally advise treading lightly when considering a vaccine mandate. I’m interested to hear what you think: should employers be mandating vaccines for their employees or do the potential cons—namely, harm to company culture and probable litigation—still outweigh the pros? Let me know at [email protected].